UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis

The New England journal of medicine, 2009-12, Vol.361 (23), p.2296-2297

2009

Volltextzugriff (PDF)

Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses

The Journal of infectious diseases, 2010-03, Vol.201 (5), p.740-745

2010

Volltextzugriff (PDF)

Comparison of Risk Factors for Human Metapneumovirus and Respiratory Syncytial Virus Disease Severity in Young Children

The Journal of infectious diseases, 2012-07, Vol.206 (2), p.178-189

2012

Volltextzugriff (PDF)

The REinfection in COVID‐19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers

Influenza and other respiratory viruses, 2022-09, Vol.16 (5), p.916-925

2022

Volltextzugriff (PDF)

Duration of isolation and contagiousness in coronavirus disease 2019 (COVID-19) patients receiving tocilizumab and dexamethasone: A case series

Infection control and hospital epidemiology, 2023-04, Vol.44 (4), p.655-658

2023

Volltextzugriff (PDF)

Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis

The New England journal of medicine, 2009-12, Vol.361 (23), p.2296-2297

2009

Volltextzugriff (PDF)

Household Transmission of the 2009 Pandemic A/H1N1 Influenza Virus: Elevated Laboratory-Confirmed Secondary Attack Rates and Evidence of Asymptomatic Infections

Clinical infectious diseases, 2010-11, Vol.51 (9), p.1033-1041

2010

Volltextzugriff (PDF)

Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada

International journal of infectious diseases, 2023-06, Vol.131, p.119-126

2023

Volltextzugriff (PDF)

Infection‐induced seroconversion and seroprevalence of SARS‐CoV‐2 among a cohort of children and youth in Montreal, Canada

Influenza and other respiratory viruses, 2023-08, Vol.17 (8), p.e13186-n/a

2023

Volltextzugriff (PDF)

Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice

Vaccine, 2020-02, Vol.38 (9), p.2122-2127

2020

Volltextzugriff (PDF)

Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets

PLoS pathogens, 2010-07, Vol.6 (7), p.e1001015-e1001015

2010

Volltextzugriff (PDF)

Effect of Ribavirin and Glucocorticoid Treatment in a Mouse Model of Human Metapneumovirus Infection

Antimicrobial Agents and Chemotherapy, 2006-02, Vol.50 (2), p.774-777

2006

Volltextzugriff (PDF)

Protease‐activated receptor 1 inhibition protects mice against thrombin‐dependent respiratory syncytial virus and human metapneumovirus infections

British journal of pharmacology, 2018-01, Vol.175 (2), p.388-403

2018

Volltextzugriff (PDF)

Human Metapneumovirus: A New Player among Respiratory Viruses

Clinical infectious diseases, 2004-04, Vol.38 (7), p.983-990

2004

Volltextzugriff (PDF)

Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine

Frontiers in immunology, 2022-10, Vol.13, p.930252

2022

Volltextzugriff (PDF)

Infection with Human Metapneumovirus Predisposes Mice to Severe Pneumococcal Pneumonia

Journal of Virology, 2009-02, Vol.83 (3), p.1341-1349

2009

Volltextzugriff (PDF)

Human metapneumovirus activates NOD-like receptor protein 3 inflammasome via its small hydrophobic protein which plays a detrimental role during infection in mice

PLoS pathogens, 2019-04, Vol.15 (4), p.e1007689-e1007689

2019

Volltextzugriff (PDF)

Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada

JAMA network open, 2021-11, Vol.4 (11), p.e2135975-e2135975

2021

Volltextzugriff (PDF)

Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: protocol for a cohort study in Montreal, Canada

BMJ open, 2021-07, Vol.11 (7), p.e053245-e053245

2021

Volltextzugriff (PDF)

Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in mice

Journal of general virology, 2018-10, Vol.99 (10), p.1367-1380

2018

Volltextzugriff (PDF)

Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model

PloS one, 2013-08, Vol.8 (8), p.e72529-e72529

2013

Volltextzugriff (PDF)

Mutations in the fusion protein heptad repeat domains of human metapneumovirus impact on the formation of syncytia

Journal of general virology, 2017-06, Vol.98 (6), p.1174-1180

2017

Volltextzugriff (PDF)

Engineering of Live Chimeric Vaccines against Human Metapneumovirus

Pathogens (Basel), 2020-02, Vol.9 (2), p.135

2020

Volltextzugriff (PDF)

Identification and Evaluation of a Highly Effective Fusion Inhibitor for Human Metapneumovirus

Antimicrobial Agents and Chemotherapy, 2008-01, Vol.52 (1), p.279-287

2008

Volltextzugriff (PDF)

Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice

Antimicrobial agents and chemotherapy, 2014-11, Vol.58 (11), p.6398-6405

2014

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(93)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis

Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses

Comparison of Risk Factors for Human Metapneumovirus and Respiratory Syncytial Virus Disease Severity in Young Children

The REinfection in COVID‐19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers

Duration of isolation and contagiousness in coronavirus disease 2019 (COVID-19) patients receiving tocilizumab and dexamethasone: A case series

Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis

Household Transmission of the 2009 Pandemic A/H1N1 Influenza Virus: Elevated Laboratory-Confirmed Secondary Attack Rates and Evidence of Asymptomatic Infections

Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada

Infection‐induced seroconversion and seroprevalence of SARS‐CoV‐2 among a cohort of children and youth in Montreal, Canada

Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice

Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets

Effect of Ribavirin and Glucocorticoid Treatment in a Mouse Model of Human Metapneumovirus Infection

Protease‐activated receptor 1 inhibition protects mice against thrombin‐dependent respiratory syncytial virus and human metapneumovirus infections

Human Metapneumovirus: A New Player among Respiratory Viruses

Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine

Infection with Human Metapneumovirus Predisposes Mice to Severe Pneumococcal Pneumonia

Human metapneumovirus activates NOD-like receptor protein 3 inflammasome via its small hydrophobic protein which plays a detrimental role during infection in mice

Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada

Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: protocol for a cohort study in Montreal, Canada

Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in mice

Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model

Mutations in the fusion protein heptad repeat domains of human metapneumovirus impact on the formation of syncytia

Engineering of Live Chimeric Vaccines against Human Metapneumovirus

Identification and Evaluation of a Highly Effective Fusion Inhibitor for Human Metapneumovirus

Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice

Suchergebnisse filtern